Stockscreener 앱 받기
0.9759
3.71%
0.0349
시간 외 거래:
.98
0.0041
+0.42%
Elutia Inc 주식(ELUT)의 최신 뉴스
Elutia Inc (ELUT) Stock News Today - TradingKey
Elutia Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:ELUT) 2026-08-16 - Seeking Alpha
Downgrade: What You Need To Know About The Latest Elutia Inc. (NASDAQ:ELUT) Forecasts - simplywall.st
Elutia secures $26M to launch NXT-41x, targetin... - Pluang
Elutia Secures Up to $26 Million to Fund NXT-41x Through Commercial Launch; Reports Second Quarter 2026 Results - Sahm
Elutia Q2 2026 slides: $26M capital raise funds NXT41x launch - Investing.com Australia
Elutia Inc. (ELUT): SilverArc Capital reports 4.9% stake in Class A shares - Stock Titan
Elutia Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Elutia Inc (ELUT) (Q2 2026) Earnings Call Highlights: Strategic - GuruFocus
ELUT Looks 2.2% Undervalued on GF Value™ Amid Challenging Sales and Cash Flow - GuruFocus
Elutia Inc. (NASDAQ: ELUT) Share Price, ELUT Stock News, ELUT Share Price & Updates - kalkine.ca
Earnings call transcript: Elutia Q2 2026 revenue miss offset by margin gains - Investing.com Nigeria
ELUT: Q2 delivered improved margins, strong funding, and high surgeon demand for NXT-41x - TradingView
Elutia secures $26M in capital, expects FDA decision on NXT-41 - Investing.com Australia
Elutia Q2 2026 Earnings Call Transcript - Benzinga
ELUT: Improved margins, strong funding, and high surgeon demand set up NXT-41x for 2028 launch - TradingView
Elutia Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Elutia Inc. Secures $15 Million Loan Financing from Avenue Capital Group to Fund NXT-41X Launch in $1.5 Billion Plastic and Reconstructive Surgery Market - marketscreener.com
Elutia Inc. (ELUT) Stock Falls on Q2 2026 Earnings - Quiver Quantitative
Is Elutia Inc (ELUT) Positioned for Growth After Q2 Earnings? EPS at -$0.15, Revenue at $2.90M -- GF Score: 34/100 - GuruFocus
Elutia Secures $15 Million Loan Financing From Avenue Capital Group - TradingView
Elutia secures $15 million financing for product development - Investing.com
Elutia Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Elutia 2Q Sales $2.43M >ELUT - Moomoo
Elutia's Biomatrix Targets 15–20% Infection Rates in Plastic Surgery - Stock Titan
Elutia Secures $15 Million Loan Financing from Avenue Capital Group to Fund NXT-41x Launch in $1.5 Billion Plastic and Reconstructive Surgery Market - marketscreener.com
Earnings To Watch: Elutia Inc (ELUT) Q2 2026 -- GF Value Sees 6% Downside - Yahoo Finance
Elutia Inc expected to post a loss of 15 cents a shareEarnings Preview - tradingview.com
Elutia Inc. (ELUT) stake of 2.19M shares reported by SilverArc - Stock Titan
Elutia | 8-K: Current report - Moomoo
Elutia Receives Nasdaq Notice on Listing Compliance Risk - The Globe and Mail
Elutia Inc (ELUT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Elutia | 4: Statement of changes in beneficial ownership of securities-Director Makes Brigid - Moomoo
Elutia Inc. (ELUT) Files Form 8-K: Nasdaq-Listed Delaware Biologics Company Updates Corporate Information - Minichart
Earnings Preview: Elutia to Report Financial Results Post-market on August 13 - Moomoo
Elutia Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Elutia Inc. (NASDAQ: ELUT) faces Nasdaq minimum bid price deficiency - Stock Titan
Elutia to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026 - The Manila Times
Elutia Inc. (ELUT) Q1 2026 Earnings: EPS Miss Weighs on Shares Amid Revenue DisclosuresConsensus Forecast Report - dars.gov.et
Elutia Inc (ELUT) Institutional Confidence - TradingKey
Elutia Inc (ELUT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Elutia Inc (ELUT) Cash Flow - TradingKey
Elutia Inc (ELUT) Balance Sheet - TradingKey
Elutia Inc (ELUT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Elutia Inc (ELUT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Elutia Inc (ELUT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TradingKey - TradingKey
ELUT|Elutia Inc|Price:0.930|Chg%:-0.003 - TradingKey
Elutia Inc (ELUT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Elutia, Inc. Revenue Breakdown – NASDAQ:ELUT - TradingView
Elutia, Inc. Revenue Breakdown – BOATS:ELUT - TradingView
Elutia Sells SimpliDerm Business for Up to $11M to Fund NXT-41x Launch in $1.5B Plastic Surgery Market 1 - Minichart
Elutia Divests SimpliDerm Assets to Refocus Strategy - TipRanks
Lake Street Reaffirms Their Buy Rating on Elutia (ELUT) - The Globe and Mail
Elutia Sheds Legacy Business to Chase $1.5 Billion Market Opportunity - Benzinga
2.43%
자본화:
|
볼륨(24시간):